AFG
EW icon

Atomi Financial Group’s Edwards Lifesciences EW Stock Holding History

Atomi Financial Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$495K Sell
5,469
-482
-8% -$40.4K 0.01% 775
2026
Q1 		$477K Buy
5,951
+2,030
+52% +$167K 0.01% 731
2025
Q4 		$334K Buy
3,921
+678
+21% +$55.6K 0.01% 883
2025
Q3 		$252K Buy
3,243
+416
+15% +$32.5K 0.01% 986
2025
Q2 		$221K Buy
+2,827
New +$211K 0.01% 993
2024
Q3 		– Sell
-4,458
Closed -$412K – 921
2024
Q2 		$412K Buy
4,458
+274
+7% +$24.3K 0.03% 451
2024
Q1 		$400K Buy
+4,184
New +$351K 0.04% 424

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Atomi Financial Group's EW Position: Q2 2026 in Review

Atomi Financial Group reduced its Edwards Lifesciences (EW) stake by 8.1% in Q2 2026, selling an estimated $40.4K and leaving 5,469 shares worth $495K. The position accounts for 0.01% of the portfolio, ranked #775.

Atomi Financial Group first reported a position in EW in Q1 2024 and has held it in 7 quarters since. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Atomi Financial Group held 5,469 shares of Edwards Lifesciences worth $495K as of Q2 2026.
  • Atomi Financial Group sold 482 Edwards Lifesciences shares in Q2 2026, an estimated $40.4K.
  • Edwards Lifesciences made up 0.01% of Atomi Financial Group's portfolio in Q2 2026, its #775 holding.
  • Atomi Financial Group first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 7 quarters since.
  • 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.